Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Acquisitions (2017 - 2021)

LivaNova recorded quarterly Acquisitions of $1.7 million in Q4 2021, down 1.45% quarter-over-quarter from $1.7 million in Q4 2020, and down 1.45% year-over-year from $1.7 million in Q4 2020.

LivaNova's Acquisitions history runs 5 years deep, the most recent figure standing at $1.7 million for Q4 2021.

  • In Q4 2021, Acquisitions fell 1.45% year-over-year to $1.7 million; the TTM figure through Sep 2023 stood at $1.7 million (down 50.37% YoY), while the FY2022 annual figure was $8.9 million, up 422.85% from the prior year.
  • Acquisitions came in at $1.7 million for Q4 2021 at LivaNova, down from $1.7 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $202.2 million in Q2 2018 to a low of -$172000.0 in Q4 2018.
  • A 5-year average of $44.0 million and a median of $10.8 million in 2019 frame the typical range for Acquisitions.
  • Across the five-year window, Acquisitions jumped 1324.79% in 2018 and sank 94.68% in 2019, its largest moves.
  • LivaNova's Acquisitions stood at $14.2 million in 2017, then plunged by 101.21% to -$172000.0 in 2018, then surged by 6350.0% to $10.8 million in 2019, then plunged by 84.01% to $1.7 million in 2020, then retreated by 1.45% to $1.7 million in 2021.
  • According to Business Quant data, Acquisitions over the past three periods registered $1.7 million, $1.7 million, and $10.8 million for Q4 2021, Q4 2020, and Q2 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 LivaNova 4.03 Bn 3.45 Bn 243.75 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 1.69 Mn
Dec 31, 2020 1.72 Mn
Jun 30, 2019 10.75 Mn
Dec 31, 2018 -172,000.00
Jun 30, 2018 202.23 Mn
Mar 31, 2018 77.63 Mn
Jun 30, 2017 14.19 Mn